These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15566516)

  • 1. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
    Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
    Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice.
    Tang Y; Katuri V; Dillner A; Mishra B; Deng CX; Mishra L
    Science; 2003 Jan; 299(5606):574-7. PubMed ID: 12543979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis.
    Wang Z; Liu F; Tu W; Chang Y; Yao J; Wu W; Jiang X; He X; Lin J; Song Y
    J Cell Mol Med; 2012 Jan; 16(1):118-28. PubMed ID: 21388516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture.
    Zhao J; Lee M; Smith S; Warburton D
    Dev Biol; 1998 Feb; 194(2):182-95. PubMed ID: 9501027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.
    Weinstein M; Monga SP; Liu Y; Brodie SG; Tang Y; Li C; Mishra L; Deng CX
    Mol Cell Biol; 2001 Aug; 21(15):5122-31. PubMed ID: 11438667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.
    Baek HJ; Lim SC; Kitisin K; Jogunoori W; Tang Y; Marshall MB; Mishra B; Kim TH; Cho KH; Kim SS; Mishra L
    Hepatology; 2008 Oct; 48(4):1128-37. PubMed ID: 18704924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
    EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
    Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
    Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
    Kitisin K; Ganesan N; Tang Y; Jogunoori W; Volpe EA; Kim SS; Katuri V; Kallakury B; Pishvaian M; Albanese C; Mendelson J; Zasloff M; Rashid A; Fishbein T; Evans SR; Sidawy A; Reddy EP; Mishra B; Johnson LB; Shetty K; Mishra L
    Oncogene; 2007 Nov; 26(50):7103-10. PubMed ID: 17546056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Smad3 in acute T-cell lymphoblastic leukemia.
    Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ
    N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
    Kelley TJ; Elmer HL; Corey DA
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.
    Tannehill-Gregg SH; Kusewitt DF; Rosol TJ; Weinstein M
    Vet Pathol; 2004 May; 41(3):278-82. PubMed ID: 15133179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.